This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chinese Academy of Sciences. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Feifei Fang: Innovator in Pharmaceutical Chemistry
Introduction
Feifei Fang is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that can be used in cancer treatment. Her work is characterized by a focus on innovative solutions that address critical health challenges.
Latest Patents
Feifei Fang holds a patent for a fused-cyclic pyrazolone formamide compound and its preparation method. This patent, which includes a pharmaceutical composition and its use, provides a class of compounds that can serve as AXL inhibitors. These compounds are particularly valuable in the preparation of pharmaceutical compositions aimed at treating tumors. The specific structure of the compound is detailed in the patent documentation, showcasing her innovative approach to drug development.
Career Highlights
Feifei Fang is affiliated with the Chinese Academy of Sciences, where she has been instrumental in advancing research in her field. Her dedication to innovation and excellence has positioned her as a key figure in pharmaceutical research. With a focus on developing effective treatments, she continues to contribute to the scientific community.
Collaborations
Feifei Fang has collaborated with notable colleagues, including Jian Ding and Hong Liu. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in pharmaceutical chemistry.
Conclusion
Feifei Fang's work exemplifies the impact of innovative research in the pharmaceutical industry. Her contributions, particularly in the development of compounds for cancer treatment, highlight the importance of scientific advancement in improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
